ArticleFrontiers in pharmacology2022

Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysis.

Teresa Barcina Lacosta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.